Academic History
Nicholas James, MBBS, PhD, is Professor of Prostate and Bladder Cancer Research at the Institute of Cancer Research and the Royal Marsden Hospital, London, UK. He completed degrees in medicine and immunology at the University of London and went on to earn a PhD in cell cycle biology from Imperial College, London, UK.
The research of Prof. James focuses on advanced prostate cancer and bladder preservation strategies for locally advanced bladder cancer. He is the Chief Investigator of the STAMPEDE trial, a landmark study evaluating multiple therapies for advanced prostate cancer, involving over 11,000 men – the findings had a global impact on clinical practice. Additionally, he has led trials demonstrating that low-dose synchronous chemotherapy can significantly reduce invasive bladder cancer relapse rates, as published in The New England Journal of Medicine.
Speaking on advancing prostate cancer treatment and clinical trial design
Prof. James designs and leads clinical trials to explore innovative treatment approaches for prostate cancer. His work is centered on the development and refinement of new therapies through cutting-edge trial designs and the use of biomarkers to guide patient care. As a principal investigator in multiple trials, Prof. James continues to advance clinical research, contributing significantly to the advancement of prostate cancer treatment.
